BROKEN BOW, Neb., Oct. 16, 2025 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, proudly commemorates 65 years of manufacturing excellence at its Broken Bow, Nebraska facility—a cornerstone […]
Tag: Dickinson and Company)
BD to Present at the 7th Annual Evercore ISI HealthCONx Conference
FRANKLIN LAKES, N.J., Nov. 19, 2024 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the 7th Annual Evercore ISI HealthCONx Conference […]
New Data Reveals BD’s Artificial Intelligence Software Highly Effective in Detecting Indicators of Controlled Substance Diversion
FRANKLIN LAKES, N.J., Sept. 26, 2024 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced new data that highlights how its advanced artificial intelligence technology can help health […]
BD Expands Capacity for Advanced Prefillable Syringes and Enhances Injection Experience for the Next Generation of Biologics
LE PONT-DE-CLAIX, France, Sept. 18, 2024 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced the commercial release of the BD Neopak™ XtraFlow™ Glass Prefillable Syringe and the latest […]
BD Completes Acquisition of Critical Care from Edwards Lifesciences
Expands BD’s portfolio of smart connected care solutions with leading monitoring technologies, including advanced AI-enabled clinical decision tools Combination of leading monitoring and infusion platforms enables future innovation opportunities for closed–loop monitoring and treatment, integrating […]